Analyst Price Targets — ALDX
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| October 8, 2025 4:49 pm | Clara Dong | Jefferies | $7.00 | $5.62 | TheFly | Aldeyra price target raised to $7 from $6 at Jefferies |
| October 3, 2024 9:30 am | Justin Kim | Oppenheimer | $12.00 | $5.14 | StreetInsider | Oppenheimer Reiterates Outperform Rating on Aldeyra Therapeutics (ALDX) |
| April 3, 2024 7:08 am | Justin Kim | Oppenheimer | $10.00 | $3.55 | StreetInsider | Oppenheimer Upgrades Aldeyra Therapeutics (ALDX) to Outperform |
| April 2, 2024 6:08 am | Matt Caufield | H.C. Wainwright | $10.00 | $3.27 | StreetInsider | H.C. Wainwright Reinstates Aldeyra Therapeutics (ALDX) at Buy |
Latest News for ALDX
Highly Experienced US-Based Public Markets Leader Strengthens Team as Company Drives Late Stage Development of LEVI-04 for Osteoarthritis Highly Experienced US-Based Public Markets Leader Strengthens Team as Company Drives Late Stage Development of LEVI-04 for Osteoarthritis
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immun
LEXINGTON, Mass.--(BUSINESS WIRE)--Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated diseases, today announced the appointment of Darlene Deptula-Hicks to Aldeyra's board of directors (the Board). “Ms. Deptula-Hicks brings decades of experience working with both publicly traded and venture-backed…
Aldeyra Therapeutics NASDAQ: ALDX Chief Executive Todd Brady said the company expects near-term feedback from the U.S. Food and Drug Administration on its dry eye disease candidate reproxalap, following a third complete response letter tied to efficacy questions.
LEXINGTON, Mass.--(BUSINESS WIRE)--Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated diseases, today announced that Todd C. Brady, M.D., Ph.D., President and Chief Executive Officer, will participate in a fireside chat at the 2026 Jefferies Global Healthcare Conference in New York, New York. Dr.…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for ALDX.
U.S. House Trading
No House trades found for ALDX.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.